ArticleThe patient2022

Exit Interviews Examining the Patient Experience in Clinical Trials of Tirzepatide for Treatment of Type 2 Diabetes.

Louis S Matza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.